Send feedback

PTEN p.Arg130Leu

c.389G>T · rs121909229 · VCV376509

Pathogenic/Likely pathogenic Multiple submitters
Classification
Pathogenic/Likely pathogenic
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 12 submitters
AlphaMissense
likely pathogenic
0.9997 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 8.48e-05%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
3
hereditary neoplastic syndrome

Computational evidence

Protein change
AlphaMissense0.9997likely pathogenic ✓ concordant with ClinVar · top 8% in PTEN
REVEL0.987strongly pathogenic-leaning
SaProtLLR -13.99damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 10GERP 2.4, phastCons 1
Regional constrainto/e 0.51unconstrained · MANE · 32 kb · p 4.1e-17 · regional, not allelic
Overall
CADD34.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.48e-05% European (non-Finnish) · 1/1,179,864 alleles
Overall 6.84e-05% 1/1,461,692 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PTEN
Protein
p.Arg130Leu
Coding
c.389G>T
MANE Select
NM_000314
dbSNP
rs121909229
Type
single nucleotide variant
Location
chr10:87933148 (GRCh38)
Gene constraint
LOEUF 0.685 · pLI 0.05 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 83.76 · 12 PDB
Residue 130
an α-helix; the phosphatase tensin-type domain; a UniProt-annotated variant site (in mcephas); a UniProt-annotated variant site (in cws1; loss of phosphatase activity towards ins(1,3,4,5)p4 and ptdins(3,4,5)p3); a UniProt-annotated variant site (in cws1; also found in endometrial hyperplasia; loss of phosphatase activity towards ins(1,3,4,5)p4; retains ability to bind phospholipid membranes); a UniProt-annotated variant site (in cws1; loss of phosphatase activity towards ins(1,3,4,5)p4; retains ability to bind phospholipid membranes)
Full PTEN gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pten-p-arg130leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown